DXE-13775-22050
3 vaccinations
3 coded responses
3 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 222 / VA
- Registered
- 2021-12-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
2GM-57878-64638
Child or adolescent in my care · Male · 2021-12-12
Timeline
-
2020-12-16
Dose 1 — Pfizer-BioNTech
-
2021-01-06
Dose 2 — Pfizer-BioNTech
-
2021-10-15
Dose 3 — Pfizer-BioNTech
-
2021-12-12
Registered in v-safe
-
2022-01-14
Survey response — 3 months, dose 3MedDRA: Oropharyngeal pain — Feeling: GoodFree text: Sore throatMedDRA releases: 2024-11 · check-in free text available
-
2022-04-18
Survey response — 6 months, dose 3MedDRA: Cough, Fatigue, Nasopharyngitis, Oropharyngeal pain, Pyrexia, Respiratory tract congestion — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Caught a cold from child-fever, cough, congestion, fatigue, sore throatMedDRA releases: 2024-11 · check-in free text available
-
2022-04-18
Report sent to call center — 6 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-04-19
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-10-17
Survey response — 12 months, dose 3MedDRA: COVID-19, Respiratory tract infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Contracted COVID 22 Sept 2022; other non-COVID respiratory infection 24 August 2022MedDRA releases: 2024-11 · check-in free text available
-
2022-10-17
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-10-18
- 2022-10-19
-
2022-10-19
Callback requested for03:00PM ET
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-16 | Pfizer-BioNTech | No |
| 2 | 2021-01-06 | Pfizer-BioNTech | No |
| 3 | 2021-10-15 | Pfizer-BioNTech | No |
Call center
2 call center cases
1 successful · 1 unsuccessful
Free text
Release 10 — 3 months, dose 3
Symptoms: Sore throat
Release 11 — 6 months, dose 3
Symptoms: Caught a cold from child-fever, cough, congestion, fatigue, sore throat
Release 12 — 12 months, dose 3
Symptoms: Contracted COVID 22 Sept 2022; other non-COVID respiratory infection 24 August 2022
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Respiratory tract infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release